Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrrolate vs Hyoscine for Clozapine-Induced Hypersalivation
NCT02613494Phase 2Completed
- Sponsor
- Mersey Care NHS Foundation Trust
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glycopyrronium in sialorrhea (3 arms), sponsored by Mersey Care NHS Foundation Trust. Primary endpoints: Number of participants recruited at 20 months and Number of participants finishing the study at 20 months. Started Jan 2016; status: completed.
02
Drugs
glycopyrronium
03
Conditions
sialorrhea
Beyond the preview
Go deeper on NCT02613494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02613494.